Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 2.36Cr 2.07Cr 1.95Cr 1.78Cr 3.33Cr 226.31Cr 3.35Cr 23Cr 9.08Cr 115.38Cr 8.87Cr 8.68Cr 374.09Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.7Cr 3.48Cr 3.18Cr 5.95Cr 404.09Cr 5.99Cr 42Cr 16Cr 206.02Cr 16Cr 15Cr 667.97Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Current month-15.38%
1 month+100.00%
3 months-46.34%
6 months-56.00%
Current year-33.33%
1 week 0
Extreme 0.0022
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-57.69%+100.00% 8L
-2.56%0.00%-33.33%-50.90% 174.6Cr
-3.19%+0.50% - - 159.16Cr
+0.05%-2.20%-29.59%+144.55% 112.5Cr
-1.05%-1.94%-45.54%+19.78% 108.18Cr
+0.29%-3.49%+203.17%+872.48% 103.15Cr
+0.30%-2.36%+41.23%+33.83% 95Cr
-0.21%+13.43%-5.97%+64.42% 81Cr
-0.54%-4.29%+11.17%+179.79% 76Cr
-7.03%+6.19%+47.92%-21.46% 56Cr
Average -1.39%-4.38%+14.60%+149.17% 96.54Cr
Weighted average by Cap. -1.51%+0.47%+17.12%+149.47%

Financials

2015 2016
Net sales 2.55Cr 2.24Cr 2.1Cr 1.92Cr 3.59Cr 244.09Cr 3.62Cr 25Cr 9.79Cr 124.44Cr 9.57Cr 9.36Cr 403.48Cr 3.23Cr 2.84Cr 2.67Cr 2.44Cr 4.56Cr 309.69Cr 4.59Cr 32Cr 12Cr 157.89Cr 12Cr 12Cr 511.92Cr
Net income 54.95L 48.23L 45.33L 41.45L 77.45L 53Cr 78.02L 5.45Cr 2.11Cr 27Cr 2.06Cr 2.02Cr 87Cr 20.61L 18.09L 17.01L 15.55L 29.05L 20Cr 29.27L 2.04Cr 79.19L 10Cr 77.41L 75.71L 33Cr
Net Debt 2.48Cr 2.18Cr 2.05Cr 1.87Cr 3.5Cr 237.61Cr 3.52Cr 25Cr 9.53Cr 121.14Cr 9.31Cr 9.11Cr 392.76Cr 1.86Cr 1.63Cr 1.53Cr 1.4Cr 2.62Cr 177.79Cr 2.64Cr 18Cr 7.13Cr 91Cr 6.97Cr 6.82Cr 293.89Cr
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
22/26/22 $0.002200 0.00% 500
16/26/16 $0.002200 -48.84% 700
  1. Stock Market
  2. Stocks
  3. AOXG Stock